Evaluation of the AllplexTM stx1/2/2a/2d Typing (ASTXT) assay for the diagnosis and typing of Shiga toxin-producing Escherichia coli

Diagn Microbiol Infect Dis. 2024 Dec 3;111(3):116645. doi: 10.1016/j.diagmicrobio.2024.116645. Online ahead of print.

Abstract

This study assessed the performance of the AllplexTM stx1/2/2a/2d Typing (ASTXT) assay (Seegene) for diagnosis and typing Shiga toxin-producing Escherichia coli. Analytical sensitivity and specificity were evaluated using 18 spiked strains, and cross-reactivity was tested on 114 strains including E. coli without Shiga toxin. Clinical performance was evaluated using the proficiency panels and 76 stool samples. Analytical sensitivity was revealed to 4.14 log10 CFU ml-1 for E. coli strain with stx1, 4.47 log10 CFU ml-1 for strain with stx2, 4.03 log10 CFU ml-1 for strain with stx2a, and 4.02 log10 CFU ml-1 for strain with stx2d, respectively. Imprecisions were within 5 % and cross-reactivity was not observed. The ASTXT assay showed perfect agreement with the proficiency panel results and achieved 100 % positive and negative percent agreement using clinical stool samples. The ASTXT assay demonstrated reliable performance for the rapid detection and typing of Shiga toxin-producing E. coli in human stool samples.

Keywords: Shiga toxin-producing Escherichia coli; stx typing; stx2a, stx2d.